2022
1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASE
Khatri R, Chhoda A, Sharma A, Farrell J, Ahuja N, Ehrlich A, Friedenberg F. 1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASE. Gastroenterology 2022, 162: s-270-s-271. DOI: 10.1016/s0016-5085(22)60641-3.Peer-Reviewed Original Research
2021
ID: 3524866 ENDOSCOPIC ULTRASOUND - FINE NEEDLE BIOPSY (EUS-FNB) DERIVED HUMAN ORGANOID MODELS IN PANCREATIC CANCER: CLINICAL AND TECHNICAL PREDICTORS OF SUCCESS
Yoo J, Nair G, Shorr E, LaComb J, Kesar V, Foster G, Joshi N, Farrell J, Buscaglia J. ID: 3524866 ENDOSCOPIC ULTRASOUND - FINE NEEDLE BIOPSY (EUS-FNB) DERIVED HUMAN ORGANOID MODELS IN PANCREATIC CANCER: CLINICAL AND TECHNICAL PREDICTORS OF SUCCESS. Gastrointestinal Endoscopy 2021, 93: ab247-ab248. DOI: 10.1016/j.gie.2021.03.535.Peer-Reviewed Original Research
2020
Su1159 FACTORS ASSOCIATED WITH “MISSED CANCERS” IN PROSPECTIVE HIGH-RISK PANCREAS CANCER SURVEILLANCE PROGRAMS. ROOM FOR IMPROVEMENT?
Chhoda A, Wattamwar K, Kastrinos F, Farrell J. Su1159 FACTORS ASSOCIATED WITH “MISSED CANCERS” IN PROSPECTIVE HIGH-RISK PANCREAS CANCER SURVEILLANCE PROGRAMS. ROOM FOR IMPROVEMENT? Gastroenterology 2020, 158: s-528. DOI: 10.1016/s0016-5085(20)32008-4.Peer-Reviewed Original ResearchPancreatic Cancer; Biomolecular and Genetic Aspects
Yoo J, Farrell J. Pancreatic Cancer; Biomolecular and Genetic Aspects. 2020, 30-38. DOI: 10.1016/b978-0-12-801238-3.65864-6.Peer-Reviewed Original ResearchPancreatic cancerGenetic aspectsNext-generation sequencingTranscriptomic analysisGenomic investigationsKey driver mutationsRecent translational advancesOverall survival rateMutational landscapeDiscrete molecular subtypesGeneration sequencingSpecific therapyLethal malignancyMolecular subtypesDisease processDriver mutationsSurvival rateTranslational advancesCancerPrecision medicineBiomolecularSequencingMutationsPathwayPatients
2019
Updated international Cancer of the Pancreas Screening (CAPS) consortium guidelines on the management of patients with increased risk for familial pancreatic cancer
Overbeek K, Canto M, Bartsch D, Brand R, Carrato A, Del Chiaro M, Farrell J, Fishman E, Fockens P, Gress T, van Hooft J, Kastrinos F, Rustgi A, Syngal S, Vasen H, Cahen D, Bruno M, Goggins M, Consortium I. Updated international Cancer of the Pancreas Screening (CAPS) consortium guidelines on the management of patients with increased risk for familial pancreatic cancer. Pancreatology 2019, 19: s56-s57. DOI: 10.1016/j.pan.2019.05.143.Peer-Reviewed Original ResearchSa1350 – Updated International Cancer of the Pancreas Screening (CAPS) Consortium Guidelines on the Management of Patients with Increased Risk for Familial Pancreatic Cancer
Overbeek K, Canto M, Bartsch D, Brand R, Carrato A, Del Chiaro M, Farrell J, Fishman E, Fockens P, Gress T, van Hooft J, Kastrinos F, Rustgi A, Syngal S, Vasen H, Cahen D, Bruno M, Goggins M. Sa1350 – Updated International Cancer of the Pancreas Screening (CAPS) Consortium Guidelines on the Management of Patients with Increased Risk for Familial Pancreatic Cancer. Gastroenterology 2019, 156: s-323. DOI: 10.1016/s0016-5085(19)37637-1.Peer-Reviewed Original Research
2017
Advanced Endoscopic Procedures
Farrell J. Advanced Endoscopic Procedures. 2017, 151-169. DOI: 10.1007/978-3-319-58256-6_8.Peer-Reviewed Original ResearchAdvanced endoscopic proceduresEndoscopic retrograde cholangiopancreatographyPancreatic cancerEndoscopic proceduresEndoscopic ultrasoundMultidisciplinary management approachManagement of patientsPalliation of patientsEndoscopic enteral stent placementEnteral stent placementRetrograde cholangiopancreatographySurgical approachStent placementCancerPatientsPalliationCholangiopancreatographyDiagnosis
2012
Tu1556 Endoscopic Ultrasound Restaging of Gastric Cancer Following Neoadjuvant Therapy Predicts Survival
Farrell J, Battish R, Wong J, Wainberg Z, Eilber F. Tu1556 Endoscopic Ultrasound Restaging of Gastric Cancer Following Neoadjuvant Therapy Predicts Survival. Gastrointestinal Endoscopy 2012, 75: ab445. DOI: 10.1016/j.gie.2012.03.1202.Peer-Reviewed Original ResearchSa1542 Evolving Role of Endoscopic Ultrasound Before Surgery After Medical Down-Staging of Pancreaticobiliary Cancers
Paul N, Donahue T, Wong J, Tomlinson J, Hines O, Reber H, Farrell J. Sa1542 Evolving Role of Endoscopic Ultrasound Before Surgery After Medical Down-Staging of Pancreaticobiliary Cancers. Gastrointestinal Endoscopy 2012, 75: ab196. DOI: 10.1016/j.gie.2012.04.331.Peer-Reviewed Original Research
2011
Su1384 Development and Validation of an EUS-FNA-Based Predictive Marker of Gemcitabine Response in Pancreatic Cancer
Farrell J, Wong J, Donahue T, Rao J. Su1384 Development and Validation of an EUS-FNA-Based Predictive Marker of Gemcitabine Response in Pancreatic Cancer. Gastrointestinal Endoscopy 2011, 73: ab249-ab250. DOI: 10.1016/j.gie.2011.03.437.Peer-Reviewed Original Research
2008
Validation of Randomization Based on Patient Genotype Results from RTOG 9704 Trial in Pancreatic Cancer and Implications for Future Trial Design
Farrell J, Bae K, Fromm M, Regine W, Abrams R, Safran H, Hoffman J, Dicker A, Elsaleh H. Validation of Randomization Based on Patient Genotype Results from RTOG 9704 Trial in Pancreatic Cancer and Implications for Future Trial Design. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s15. DOI: 10.1016/j.ijrobp.2008.06.799.Peer-Reviewed Original Research
2005
5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) POLYMORPHISM AND PANCREATIC CANCER: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED ADJUVANT TREATMENT TRIAL
Farrell J, Winter K, Van Rijnsoever M, Regine W, Abrams R, Safran H, Hoffman J, Schaeffer P, Mohiuddin M, Macdonald J, Benson A, Willett C, Elsaleh H. 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) POLYMORPHISM AND PANCREATIC CANCER: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED ADJUVANT TREATMENT TRIAL. Pancreas 2005, 31: 440. DOI: 10.1097/01.mpa.0000193664.86654.55.Peer-Reviewed Original ResearchENDOSCOPIC ULTRASOUND FINE NEEDLE INJECTION (EUS-FNI) OF A NOVEL GENE TRANSFER THERAPY AGAINST PANCREATIC CANCER: A SINGLE INSTITUTION EXPERIENCE
Farrell J, Macko J, Hecht J. ENDOSCOPIC ULTRASOUND FINE NEEDLE INJECTION (EUS-FNI) OF A NOVEL GENE TRANSFER THERAPY AGAINST PANCREATIC CANCER: A SINGLE INSTITUTION EXPERIENCE. Pancreas 2005, 31: 440. DOI: 10.1097/01.mpa.0000193665.94277.73.Peer-Reviewed Original Research
2002
Endoscopic mucosal resection for gastric neoplasms
Farrell J, Brugge W. Endoscopic mucosal resection for gastric neoplasms. Techniques And Innovations In Gastrointestinal Endoscopy 2002, 4: 34-41. DOI: 10.1053/tgie.2002.31949.Peer-Reviewed Original ResearchEndoscopic mucosal resectionSuperficial gastric cancerMucosal resectionGastric cancerGastric endoscopic mucosal resectionLong-term clinical outcomesLong-term survival ratesResection of mucosaLong-term outcomesTreatment of patientsAssociated postoperative morbidityCurative intentPostoperative morbidityClinical outcomesGastric neoplasmsSurvival rateResectionSurgeryInvasive surgeryStrict criteriaPatientsCancerOutcomesTreatmentMorbidity